Latest S-1 registration statements

Cartesian Therapeutics files an amendment to its S-1 registration statement to allow selling stockholders to resell up to 6.5 million shares of common stock.

Synergy CHC Corp is planning a public offering of 2,000,000 shares of common stock, aiming for a Nasdaq listing and growth initiatives.

BKV Corporation's amended S-1 filing highlights its focus on natural gas production, midstream operations, power generation, and carbon capture, with a commitment to achieving net zero emissions.

Tenon Medical is offering up to 1,708,428 shares of common stock, along with warrants, to fund sales, marketing, and general corporate purposes.

MBX Biosciences, a clinical-stage biopharmaceutical company, files an amendment to its S-1 registration statement for a proposed initial public offering of 8,500,000 shares of common stock, aiming to raise approximately $114.8 million for continued development of its precision peptide therapies.

CytoDyn Inc. is registering for resale up to 486.6 million shares of its common stock by selling stockholders, as the company continues clinical development of leronlimab for various indications.

Mullen Automotive is registering for resale up to 350 million shares of its common stock by selling stockholders, derived from convertible notes and warrants.

Greenlane Holdings has filed an amendment to its Form S-1 registration statement, covering the offering and resale of up to 7,090,911 shares of common stock by selling stockholders.

Dynasty Acquisition Co. issues senior unsecured notes due in 2027, outlining terms, covenants, and agreements for the benefit of noteholders and the trustee.

Elevai Labs Inc. aims to raise up to $8 million through a public offering of common stock, pre-funded warrants, and accompanying Series A and Series B warrants.

Drugs Made In America Acquisition Corp., a blank check company targeting the pharmaceutical industry, has filed an amendment to its S-1 registration statement for a proposed $500 million initial public offering.

Invizyne Technologies Inc. files an amendment to its Form S-1 registration statement for a $15 million initial public offering, including a unique investor rights offering.

Tavia Acquisition Corp., a newly formed blank check company, aims to raise $175 million through an IPO to pursue business combinations in energy transition, circular economy, and food technologies.

Westwater Resources files for a potential $30 million stock offering through an agreement with Lincoln Park Capital Fund, aiming to bolster its graphite business and working capital.

GeoVax Labs files an S-1 registration statement for the resale of up to 975,610 shares of common stock by a selling stockholder, derived from a recent private placement.

GeoVax Labs files an S-1 registration for the resale of up to 1.7 million shares of its common stock, potentially generating proceeds for the selling stockholder upon warrant exercise.

KinderCare Learning Companies, the largest private provider of early childhood education and care in the U.S., has filed for an initial public offering on the New York Stock Exchange.

SSHT S&T Group Ltd. is launching a direct public offering of 100 million shares at $0.01 each to raise capital for working capital and general corporate purposes.

Bicara Therapeutics updates its bylaws, detailing stockholder meeting procedures and director responsibilities, as it prepares for its initial public offering.

Zenas BioPharma, a clinical-stage biopharmaceutical company, is seeking to raise $180.7 million through an initial public offering to advance its immunology-based therapies.

PACS Group, Inc. has filed a registration statement to increase the number of shares offered in its initial public offering by approximately $120.1 million.

Edible Garden AG Incorporated is offering up to 4,672,898 units, each consisting of one share of common stock or one pre-funded warrant and one warrant, to raise up to $5 million in gross proceeds.

Tianci International, Inc. is pursuing a public offering of 2,170,000 shares of common stock to fund logistics promotion, working capital, and talent recruitment, contingent upon Nasdaq Capital Market approval.

CO2 Energy Transition Corp., a blank check company targeting the carbon capture industry, has filed an amendment to its S-1 registration statement for a proposed $60 million initial public offering.

Rocky Mountain Chocolate Factory is registering for the resale of 1,250,000 shares of common stock by selling stockholders following a recent private placement.

ANEW Medical is registering for resale up to 21.5 million shares of its common stock, including shares issuable upon warrant exercises and shares held by selling stockholders.

Seaport Entertainment Group is offering stockholders the opportunity to purchase up to 7,000,000 shares at $25 each through a rights offering, backstopped by Pershing Square to ensure full subscription.

Enveric Biosciences has filed a registration statement for the resale of up to 4.9 million shares of its common stock by Lincoln Park Capital Fund, potentially generating gross proceeds of $2.45 million.

Cortigent, a neurostimulation technology company, is seeking to raise $15 million through an initial public offering to fund the development of its Orion visual prosthesis and stroke recovery system.

Jupiter Neurosciences aims to raise capital through an IPO to fund the development of its Parkinson's drug, JOTROL, and expand its business operations in Southeast Asia.